Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 1.89 USD -3.57%
Market Cap: 44.8m USD
Have any thoughts about
Accelerate Diagnostics Inc?
Write Note

Accelerate Diagnostics Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Accelerate Diagnostics Inc
Total Current Liabilities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Accelerate Diagnostics Inc
NASDAQ:AXDX
Total Current Liabilities
$13.4m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
19%
Becton Dickinson and Co
NYSE:BDX
Total Current Liabilities
$8.9B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
15%
Boston Scientific Corp
NYSE:BSX
Total Current Liabilities
$5.9B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Total Current Liabilities
$7.7B
CAGR 3-Years
20%
CAGR 5-Years
14%
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Total Current Liabilities
$13.8B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
2%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Current Liabilities
$1.7B
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
13%

See Also

What is Accelerate Diagnostics Inc's Total Current Liabilities?
Total Current Liabilities
13.4m USD

Based on the financial report for Jun 30, 2024, Accelerate Diagnostics Inc's Total Current Liabilities amounts to 13.4m USD.

What is Accelerate Diagnostics Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
19%

Over the last year, the Total Current Liabilities growth was -75%. The average annual Total Current Liabilities growth rates for Accelerate Diagnostics Inc have been 13% over the past three years , 12% over the past five years , and 19% over the past ten years .

Back to Top